Clinical and prognostic value of dynapenia in patients with head and neck cancer: a multicenter cohort study. VALOR group
Rattachement africain : es, cl. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background Head and neck cancer (HNC), particularly in patients requiring intensive multimodal treatment, may substantially impair nutritional and functional status due to tumor burden and treatment-related toxicity. Dynapenia, defined as reduced muscle strength independent of muscle mass, has emerged as a critical prognostic marker in cancer, yet its role in HNC remains underexplored. This study aimed to assess the utility of handgrip strength (HGS) in identifying dynapenia and predicting clinical outcomes, in conjunction with advanced morphofunctional tools. Methods In this prospective multicenter observational cohort study, 514 HNC patients undergoing active radiotherapy were evaluated. Muscle strength was assessed via HGS. Dynapenia was defined using two criteria: EWGSOP2 cut-offs and sex- and age-adjusted percentiles (P10) from Spanish normative data (dynapenia-PCO). Complementary assessments included bioelectrical impedance analysis (phase angle [PA], standardized phase angle [SPA], body cell mass [BCM], and fat-free mass index [FFMI]), nutritional ultrasound® (rectus femoris cross-sectional area [RF-CSA]), the Timed Up and Go test (TUG), and routine biochemical parameters. Logistic regression, ROC curves, Cox proportional hazards models, and machine learning techniques (random forest and decision trees) were used to identify predictors of dynapenia and overall survival. Results Dynapenic patients presented significantly lower values of SPA, FFMI, BCM, and RF-CSA, as well as poorer performance (TUG) and nutritional biomarkers (e.g., albumin, total proteins). In multivariate logistic regression models adjusted for age, sex, and BMI, BIA (SPA: OR 0.80; p = 0.04) and ultrasound markers (RF-CSA: OR 0.62; p < 0.001) were independently associated with dynapenia. Random forest analysis identified SPA, FFMI, and TUG as the most relevant predictors of dynapenia (mean decrease accuracy >10), and combined ROC analysis for these three variables achieved an AUC of 0.77 (95% CI: 0.715–0.831; p < 0.001). Regarding prognosis, dynapenia-PCO showed the highest predictive power for mortality, with a hazard ratio (HR) of 2.95 (95% CI: 1.49–5.88; p < 0.01) in Cox regression. Conclusion In HNC patients, dynapenia defined by population-based percentiles provides a robust marker of impaired body composition and reduced survival. The integration of simple functional tools like dynamometry with advanced morphofunctional assessments offers a comprehensive and feasible strategy to identify high-risk patients.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Clinical and prognostic value of dynapenia in patients with head and neck cancer: a multicenter cohort study. VALOR group
- Date Crossref
- 19/08/2026
- Éditeur
- Frontiers Media SA
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Hospital Quirónsalud Barcelona Jerez de la Frontera pays non établi dans la noticeÉtablissement de santé
-
Hospital Clínico Universitario Virgen de la Victoria pays non établi dans la noticeÉtablissement de santé
-
Instituto de Investigación Biomédica de Málaga IBIMA Plataforma BIONAD pays non établi dans la noticeStructure de recherche
-
Universidad de Málaga pays non établi dans la noticeUniversité ou école supérieure
-
Instituto de Investigación Biosanitaria de Granada pays non établi dans la noticeStructure de recherche
-
Fundación para la Investigación Biosanitaria de Andalucía Oriental - Alejandro Otero pays non établi dans la noticeOrganisation à but non lucratif
-
Hospital Regional Universitario de Málaga Endocrinology and Nutrition Department pays non établi dans la noticeÉtablissement de santé
-
Hospital Universitario Virgen de las Nieves pays non établi dans la noticeÉtablissement de santé
-
Biomedical Research and Innovation Institute of Cadiz pays non établi dans la noticeStructure de recherche
-
Hospital Universitario Puerta del Mar Endocrinology and Nutrition Department pays non établi dans la noticeÉtablissement de santé
-
Complejo Hospitalario de Jaén pays non établi dans la noticeÉtablissement de santé
-
Universidad de La Frontera pays non établi dans la noticeUniversité ou école supérieure
Jerez de la Frontera — Hospital Quirónsalud Barcelona, Hospital Clínico Universitario Virgen de la Victoria et IBIMA Plataforma BIONAD — Instituto de Investigación Biomédica de Málaga, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.